DUBLIN--(BUSINESS WIRE)--The "Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering. "Vitamin D Receptor ...
Activating the vitamin D receptor shows promise in controlling harmful cell growth linked to pulmonary hypertension, a major factor in disease progression and patient prognosis. Study: Vitamin D ...
Diseases Like CKD, Cancers, and Psoriasis Can Benefit from the Blocking of CYP24 Activity Emerging data from new research suggests that abnormally elevated CYP24 expression contributes to the ...
Intraprostatic vaccine administration in patients with locally recurrent prostate cancer. Background: Inecalcitol is a novel vitamin D receptor (VDR) agonist which shows high antiproliferative effects ...
The problem is so prevalent in CKD and dialysis patients that most will require supplementation. The active forms of vitamin D—calcitriol, paricalcitol, and doxercalciferol—which also are known as ...
A form of vitamin D could protect us against damage from low levels of radiation according to new research in the International Journal of Low Radiation. Radiological health expert Daniel Hayes, Ph.D.
In a recent study published in the journal Nutrients, researchers explored the role of vitamin D receptors (VDR) as a potential prognostic marker for breast cancer. Their results indicate significant ...
Radiological health expert Daniel Hayes, Ph.D., of the New York City Department of Health and Mental Hygiene suggests that a form of vitamin D could be one of our body's main protections against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results